The total return over the past 12 months is +23.74% vs. +16.94% for the S&P 500. So far it's up +52.53% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +23.74% | +7.89% | N/A | N/A | N/A | N/A |
| Total Return CAGR | +23.74% | +7.89% | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Sagimet Biosciences Inc. (SGMT)
| Year | Start price | End price | SGMT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.92 | $9.03 | +52.53% | +14.51% | +38.02% |
| 2025 | $4.50 | $5.92 | +31.56% | +17.72% | +13.84% |
| 2024 | $5.42 | $4.50 | (16.97%) | +24.89% | (41.86%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
